Track topics on Twitter Track topics that are important to you
Antifungal drugs are used to cure fungal infections, which occur due to unclean, unhygienic, and damp environment. Fungal infections are caused by microscopic organisms invading epithelial tissue. Systemic fungal infections are usually caused by the indigestion or inhalation of fungus spores and cause fungal pneumonia, and opportunistic fungus causes diseases, such as candidiasis, meningitis, mucormycosis, etc. The global antifungal drugs market is expected to register a CAGR of 3.7% during the forecast period, 2018 to 2023.
Increasing Number of Antifungal Drugs as OverTheCounter OTC
With rising popularity of overthecounter OTC drugs, many patients prefer them to obtaining a prescription from a healthcare professional. Numerous common and harmless fungal infections are left untreated by patients, owing to medical costs and logistical constraints. These have directly contributed to the rise in the usage of OTC drugs, as these infections can be treated by OTC drugs, owing to their ease of availability.
Increasing awareness about myriad fungal infections and increasing government and corporate funding are some other drivers of the market.
Presence of Generics and Government Regulations in the Pharmaceutical Industry
Although there is an increase in the sales of antifungal generic drugs, the market value of these drugs has decreased, as the price of generics is almost 20 to 50% of the branded drugs. To meet the market value, the sales of generics must be increased by at least four times to that of branded drugs. Even with the increasing volume of generic antifungal drug sales, the overall market value of antifungal drugs has reduced.
Additionally, high penetration of conventional drugs used for treatment and allergic reaction to some types of antifungal drugs are also restraining the market growth.
North America to Dominate the Market
The global antifungal drugs market is segmented by drug type, therapeutic indication, and geography. By geography, it is segmented into North America, Europe, AsiaPacific, the Middle East Africa, and South America.
North America dominates the market due to increasing awareness of fungal infections with the growing incidence of antifungal infections and increasing government and corporate funding in the industry.
Major Players: ABBOTT LABORATORIES, PFIZER, GLAXOSMITHKLINE, BAYER HEALTHCARE, NOVARTIS, SANOFIAVENTIS, MERCK CO., KRAMER LABORATORIES, ENZON PHARMACEUTICALS, GILEAD amongst others.
Reasons to Purchase this Report
Market analysis for the global antifungal drugs market, with regionspecific assessments and competition analysis on a global and regional scale.
Analyzing various perspectives of the industry with the help of Porter's five forces analysis
The treatment type that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet in excel
Customization of the Report
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.NEXT ARTICLE
Pneumonia (bronchopneumonia, lobar pneumonia and double pneumonia) is inflammation (swelling) of the tissue in one or both of your lungs. It is usually caused by an pneumococcal infection caused by bacteria called Streptococcus pneumoniae. However,...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...